Concepedia

A. Vialichka

AV

6

Publications

212

Citations

6

H-Index

2019

Active since

Affiliations

University of Illinois Chicago(Current)

JMI Laboratories

University of Illinois Chicago, Rockford campus

A. Vialichka is an author at University of Illinois Chicago specializing in tumor microenvironment, cancer therapeutics, and tumor biology.

Top concepts

Publications per year

2019–2022

6

Publications

6

Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

Mark Biagi, X. Tan, Tian-Shung Wu et al. · Journal of Clinical Microbiology · 2019 · 59 citations · Full text

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, A. Vialichka, M. Jurkovic et al. · Antimicrobial Agents and Chemotherapy · 2020 · 55 citations · Full text

Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, D. Lamm, K. Meyer et al. · Antimicrobial Agents and Chemotherapy · 2020 · 44 citations · Full text

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

Ratika Kunder, Michelle Velyunskiy, Sara F. Dunne et al. · Cell chemical biology · 2021 · 22 citations · Full text

, , +12

Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens

Mark Biagi, Aisha Shajee, A. Vialichka et al. · Antimicrobial Agents and Chemotherapy · 2020 · 18 citations · Full text

Rows per page

1–5 of 6